Literature DB >> 18991961

Disrupting nicotine reinforcement: from cigarette to brain.

Jed E Rose1.   

Abstract

Cigarette smoking is a tenacious addiction that is maintained to a significant extent by the reinforcing effects of nicotine. An emerging theme in smoking cessation treatment is the development of methods for interfering with these reinforcing effects. By attenuating nicotine reinforcement, treatments may enhance a smoker's chances of successfully remaining abstinent. Several treatment approaches will be described, including the use of denicotinized cigarettes, nicotine vaccines, nicotinic receptor agonists and antagonists, and modulators of brain reinforcement processes. These techniques highlight the numerous sites along the path between the cigarette and the brain that can be targeted for intervention. In addition to unimodal therapies, treatment combinations will be discussed that might more effectively block cigarette reward and thereby further enhance smoking abstinence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991961     DOI: 10.1196/annals.1441.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.

Authors:  Jessica M McKlveen; Jared M Wilson; Robert T Rubin; Michael E Rhodes
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-01       Impact factor: 1.950

Review 2.  New methods for tobacco dependence treatment research.

Authors:  Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

3.  The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.

Authors:  Andrew M Smith; Gurpreet K Dhawan; Zhenfa Zhang; Kiran B Siripurapu; Peter A Crooks; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2009-07-23       Impact factor: 5.858

Review 4.  The reinforcement threshold for nicotine as a target for tobacco control.

Authors:  Mehmet Sofuoglu; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2012-05-21       Impact factor: 4.492

Review 5.  Nicotinic receptor antagonists as treatments for nicotine abuse.

Authors:  Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Adv Pharmacol       Date:  2014

6.  Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.

Authors:  Leigh V Panlilio; Zuzana Justinova; Paola Mascia; Marco Pistis; Antonio Luchicchi; Salvatore Lecca; Chanel Barnes; Godfrey H Redhi; Jordan Adair; Stephen J Heishman; Sevil Yasar; Mano Aliczki; Jozsef Haller; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

7.  Intermittent and daily smokers' subjective responses to smoking.

Authors:  Saul Shiffman; Lauren Terhorst
Journal:  Psychopharmacology (Berl)       Date:  2017-07-18       Impact factor: 4.530

8.  Vaccines in the Treatment of Substance Abuse.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  Focus (Am Psychiatr Publ)       Date:  2011-12-01

Review 9.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

10.  Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects.

Authors:  Doran J Satanove; Simon Rahman; T M Vanessa Chan; Suelynn Ren; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2020-11-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.